Results 81 to 90 of about 15,684 (181)

Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity

Frontiers in Immunology
IntroductionHIV-1 envelope (Env) is the key target for antibodies (Abs) against the virus and thus an important HIV-1 vaccine component. Env is synthesized from a gp160 precursor with a signal peptide (SP) at its N-terminus.
Chitra Upadhyay, Priyanka Rao, Mohammad Amin Behzadi, Roya Feyznezhad, Gregory S. Lambert, Rajnish Kumar, Madhu Kumar, Weiming Yang, Xunqing Jiang, Christina C. Luo, Arthur Nadas, James Arthos, Xiang-Peng Kong, Hui Zhang, Catarina E. Hioe, Catarina E. Hioe, J. Andrew Duty   +16 more
doaj   +1 more source

HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.

PLoS ONE, 2015
Human Immunodeficiency Virus (HIV-1) poses a serious threat to the developing world and sexual transmission continues to be the major source of new infections.
Tahir Bashir, Mandar Patgaonkar, Selvaa C Kumar, Achhelal Pasi, Kudumula Venkata Rami Reddy   +4 more
doaj   +1 more source

HIV Envelope Protein gp120 [PDF]

, 2020
openaire   +1 more source

Crystal structure of HERV-K envelope glycoprotein surface subunit. [PDF]

J Virol
Nikolopoulos N, Modis Y.
europepmc   +2 more sources

HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV

Journal of Translational Medicine, 2010
It is well established that HIV-1 infection typically involves an interaction between the viral envelope protein gp120/41 and the CD4 molecule followed by a second interaction with a chemokine receptor, usually CCR5 or CXCR4.
Cicala Claudia, Arthos James, Fauci Anthony   +2 more
doaj  

Tumor Necrosis Factor Receptor 2 Inhibits HIV-1 Infection by Blocking the Binding of gp120 to CD4. [PDF]

Int J Biol Sci
Gao Y, Chen Z, Chen Y, Yang Y, Wang Y, Zhu C, Liao P, Song H, Chen X.   +8 more
europepmc   +1 more source

Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response. [PDF]

J Virol
Singh S, Kumar S, Luthra K.
europepmc   +1 more source

Glycoform-Dependent Antigenicity in gp120 of HIV-1 Envelope Protein

Trends in Glycoscience and Glycotechnology, 2014
openaire   +2 more sources

From Envelope to Encephalopathy: How HIV-1 gp120 Drives Neurocognitive Decline. [PDF]

Viruses
Santerre M, Shrestha J, Allen CNS, Shcherbik N, Sawaya BE.   +4 more
europepmc   +1 more source

Research progress on HIV-1 structural proteins and antiviral therapies. [PDF]

Front Immunol
Wang H, Yuan J, Wang H.
europepmc   +1 more source